Repro-Med Systems, Inc. (OTCMKTS:REPR) Director Joseph M. Jr. Manko bought 57,000 shares of the firm’s stock in a transaction that occurred on Tuesday, November 13th. The shares were purchased at an average cost of $1.64 per share, with a total value of $93,480.00. The purchase was disclosed in a document filed with the SEC, which is available through this link.

Shares of OTCMKTS:REPR opened at $1.58 on Thursday. Repro-Med Systems, Inc. has a 12-month low of $0.64 and a 12-month high of $1.80.

Repro-Med Systems (OTCMKTS:REPR) last announced its quarterly earnings results on Wednesday, October 24th. The company reported $0.01 earnings per share (EPS) for the quarter. The company had revenue of $4.55 million during the quarter.

ILLEGAL ACTIVITY WARNING: “Joseph M. Jr. Manko Purchases 57,000 Shares of Repro-Med Systems, Inc. (REPR) Stock” was originally reported by The Cerbat Gem and is owned by of The Cerbat Gem. If you are viewing this piece of content on another domain, it was illegally copied and republished in violation of U.S. & international copyright and trademark legislation. The legal version of this piece of content can be accessed at https://www.thecerbatgem.com/2018/11/15/joseph-m-jr-manko-purchases-57000-shares-of-repro-med-systems-inc-repr-stock.html.

Repro-Med Systems Company Profile

Repro Med Systems, Inc designs, manufactures, and markets proprietary portable medical devices and supplies primarily for the ambulatory infusion market and emergency medical applications worldwide. The company offers mechanical infusion product FREEDOM infusion systems, which include the FREEDOM60 syringe infusion driver, the FreedomEdge syringe infusion driver, HIgH-Flo subcutaneous safety needle sets, RMS precision flow rate tubing, and RMS precision flow rate controller, as well as medical suction product RES-Q-VAC, a portable medical suction system.

Featured Article: Liquidity

Insider Buying and Selling by Quarter for Repro-Med Systems (OTCMKTS:REPR)

Receive News & Ratings for Repro-Med Systems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Repro-Med Systems and related companies with MarketBeat.com's FREE daily email newsletter.